Periplocin improves the sensitivity of oxaliplatin-resistant hepatocellular carcinoma cells by inhibiting M2 macrophage polarization. Biomol Biomed [Internet]. 2025 Mar. 7 [cited 2025 Mar. 10];25(4):857–868. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10928